Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...

Agilent (A) announced its PD-L1 IHC 22C3 pharmDx assay has received European IVDR certification for the use as a Companion Diagnostic to aid in ...

Pinpoint Predictive, an actuarial AI platform for property and casualty insurers, empowers carriers to quantify risk and predict loss ratios earlier and more accurately than traditional ...

Tech's Q1 2025 PV ModuleTech bankability ratings, marking the company's 21st consecutive quarter at this top tier and underscoring its long-term commitment to quality, innovation, ...

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.

Jefferies lowered the firm’s price target on Agilent (A) to $116 from $135 and keeps a Hold rating on the shares after having hosted a call ...

5 analysts have expressed a variety of opinions on Agilent Technologies A over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Teaching unions have called for more clarity on what it could mean in the classroom. The legal case centred around whether someone with a gender recognition certificate could be legally identified as ...

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences ...